Here's the coronavirus-related news from this week that you should know.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), has infected an estimated 39,068,667 individuals worldwide at publishing time, and nearly 8 million Americans. In the latest COVID-19 related news, Kroger Health is offering rapid antibody testing and a recent survey showed wide variation of acceptance rates for a vaccine.
Here’s a roundup of the latest coronavirus-related news:
Kroger Health is offering rapid antibody testing for COVID-19 across all its pharmacies and clinics by the end of November.
ThoughtSpot 2020 Series: Episode 10: Supporting Marginalized Communities During Natural Disasters
For our first episode in the ThoughtSpot 2020 series, experts from AmerisourceBergen and Healthcare Ready discuss how to support marginalized communities amid pandemics and natural disasters.
Investigators from Eli Lilly’s ACTIV-3 clinical trial investigating bamlanivimab in patients hospitalized with COVID-19 have discontinued the trial after concluding that the therapy showed no benefit. No additional COVID-19 patients in the hospitalized setting will receive bamlanivimab, according to a statement by Eli Lilly.
Results of a survey from the City University of New York Graduate School of Public Health and Health Policy showed that acceptance rates of a COVID-19 vaccine varied widely among populations; individuals who reported higher levels of trust in information from their government were more likely to accept a COVID-19 vaccine.